Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Sanofi-Aventis ADS (NY: SNY)
55.05 USD  +1.21 (+2.25%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Sanofi-Aventis ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Approaching Resistance: Sanofi-Aventis
May 21, 2013
New York, May 21st (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) are trading very close to calculated resistance at $55.77. The stock ended the trading session at just $53.84, which is... Read More
from TradersHuddle.com
New Asthma Drug Generates Excitement For Patients -- And Its Maker
May 21, 2013
 Read More
category NYSE:MRK , NYSE:SNY , NASDAQ:REGN , and 1 more.
from Forbes Real Time
Sanofi (SNY), Regeneron (REGN) Report Publication of Positive Dupilumab Phase 2a Data
May 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8357210 for the full story. Read More
from StreetInsider.com News Articles
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
May 21, 2013
Phase 2a study of the IL-4R alpha inhibitor, dupilumab, demonstrated 87% reduction in risk of asthma exacerbations in moderate-to-severe asthma patients with elevated eosinophils Read More
from PR Newswire
New Asthma Drug Could Be Game Changer
May 21, 2013
 Read More
category NYSE:SNY , NASDAQ:REGN , Hot Stocks
from InvestorPlace - Latest Headlines
Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global Consolidation
May 21, 2013
from Business Wire News Releases
Microsoft (MSFT) Flat Into Reveal of Next-Gen Xbox
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354613 for the full story. Read More
from StreetInsider.com News Articles
(BMY) Bristol-Myers Squibb Company Earns Good News From FDA
May 18, 2013
Bristol-Myers Squibb Company (BMY) recently received positive news from the US Food and Drug... Visit StockBlogHub to view complete post. Read More
category CELG , Sanofi/Aventis , Celgene Corporation , and 5 more.
from Stock Blog Hub
Sanofi (SNY) Reports JAKARTA Met Primary Endpoint in Both Groups
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8349866 for the full story. Read More
from StreetInsider.com News Articles
Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
May 17, 2013
from PR Newswire
(SNY) Sanofi Earnings Plummet – Outlook Maintained
May 16, 2013
Sanofi (SNY) reported first quarter 2013 business earnings of 81 cents per American Depository... Visit StockBlogHub to view complete post. Read More
category ADS , JNJ , Sanofi/Aventis , and 5 more.
from Stock Blog Hub
Reference Points for Sanofi-Aventis
May 16, 2013
New York, May 16th (TradersHuddle.com) - Sanofi-Aventis ( NYSE:SNY ) closed the trading day at $54.48, near its 50 day moving average that is set at $52.03. Sanofi-Aventis' price action is just above... Read More
from TradersHuddle.com
Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month
May 16, 2013
- Bettis Unveils New Playbook for Defending Against Severe Allergic Reactions and Urges Those Affected to Take Action - Read More
from PR Newswire
Finding the Next Big Blockbuster Drug
May 15, 2013
from ACCESSWIRE
Buffett's Berkshire Hathaway Enters Chicago Bridge & Iron (CBI), Sells Archer-Daniels-Midland (ADM), General Dynamics (GD)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8343832 for the full story. Read More
from StreetInsider.com News Articles
Sanofi (SNY), Regeneron (REGN) Commence COMPARE, ASCERTAIN of Sarilumab
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8339115 for the full story. Read More
from StreetInsider.com News Articles
Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
May 15, 2013
Comprehensive SARIL-RA development program to include 2,600 patients in four Phase 3 and one open-label extension trials Read More
from PR Newswire
Sanofi Smear Campaign to Limit Plavix Competition
May 14, 2013
category SNY
from YCharts
Approaching Resistance: Sanofi-Aventis
May 14, 2013
New York, May 14th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) are trading very close to calculated resistance at $55.77. The stock ended the trading session at just $54.83, which is... Read More
from TradersHuddle.com
PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial Participation
May 13, 2013
from Business Wire News Releases
Europe stocks slip after Chinese inflation data
May 09, 2013
European stock markets retreat after two positive trading days on Thursday, after higher-than-expected Chinese inflation data stoke fears the government will withhold more easing measures. Read More
category DX:DAX , Financial Services , Banks , and 16 more.
from MarketWatch
Sanofi-Aventis Is Close to Resistance
May 08, 2013
New York, May 8th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) are trading very close to calculated resistance at $55.77. The stock ended the trading session at just $53.63, which is... Read More
from TradersHuddle.com
Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio
May 08, 2013
Below are the top drug manufacturers-major stocks on the NYSE in terms of PEG ratio. WuXi PharmaTech (Cayman) (NYSE: WX ) has a PEG ratio of 1.12. WuXi PharmaTech's trailing-twelve-month revenue is... Read More
category Benzinga , JNJ , WX , and 6 more.
from Latest Articles from Benzinga.com
Sanofi-Aventis Is Close to the 50 Day Moving Average
May 07, 2013
New York, May 7th (TradersHuddle.com) - Sanofi-Aventis ( NYSE:SNY ) closed the trading day at $53.04, near its 50 day moving average that is set at $51.00. Sanofi-Aventis' price action is just above... Read More
from TradersHuddle.com
New Gold Bond® No Mess Powder Spray Introduced by Sanofi's Chattem
May 06, 2013
The same trusted formula in an easy aim spray Read More
from PR Newswire
Big Profits in Big Pharma
May 06, 2013
Don't let the less-than-stellar first quarter performances of a few well-known drug makers spook you: "Big Pharma" is a good investment over the long haul. Read More
from Update Content Feed for Financial Content
Sanofi US and Actress Elizabeth Perkins Premiere Documentary -- Diabetes Co-Stars Presents "Strength in Numbers"
May 06, 2013
-Donation to Diabetes Hands Foundation Doubled When Documentary Reaches 10,000 Views- Read More
from PR Newswire
PPH, SNY, GSK, AZN: ETF Outflow Alert
May 03, 2013
Symbols mentioned in this story: PPH, SNY, GSK, AZN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Watch for Continued Gains in Shares of Sanofi-Aventis (SNY)
May 03, 2013
from Comtex SmarTrend® News Briefs
Is Sanofi-Aventis Breaking Out?
May 03, 2013
New York, May 3rd (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) closed the session at $55.00 just above calculated resistance at $54.98. The stock moved to what appears to be a higher... Read More
from TradersHuddle.com
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
6 Healthy Products That Aren't
Diane Bullock
2
The New Microsoft Xbox One: Key Takeaways (and Red Flags) From Today's Announcement
Jake Barach and Nick Shchteko
3
Random Thoughts: A Signal That Bears Watching
Todd Harrison
4
Gold Mining Stocks: 10 Reasons It's Time to Be Brave
David Banister
5
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper

Financial Product Guide